CBDNewsBreaks – Software Effective Solutions Corp. (d/b/a MedCana) (SFWJ) Responds to Announcement Rescheduling of Marijuana by DEA

Software Effective Solutions Corp. (d/b/a MedCana) (OTC: SFWJ), a holding company focused in the cannabis and agricultural technology sectors, released an official reaction to the “historic milestone” in the cannabis industry as the U.S. Drug Enforcement Administration (“DEA”) moves to reclassify cannabis from Schedule I to Schedule III under the Controlled Substances Act (“CSA:). The reclassification was fueled by a recommendation from the U.S. Department of Health and Human Services and represents a notable change in U.S. drug policy. According to the announcement from MedCana, cannabis has been unjustly categorized as a Schedule I substance alongside heroin and LSD for more than four decades, even though the substance exhibits medical benefits and has low potential for abuse. “The DEA’s move to reschedule cannabis acknowledges its therapeutic value and aligns with evolving attitudes towards cannabis policy,” the announcement stated. The DEA’s proposed reclassification will undergo public comment, and MedCana noted that it is committed to advancing the dialogue around cannabis policy and supporting initiatives that promote responsible use and access to quality cannabis products. “The DEA’s decision to reclassify cannabis is a watershed moment in our nation’s drug policy,” said MedCana CEO Jose Gabriel Diaz in the press release. “It opens the door to further research, innovation and accessibility, signaling a new era of acceptance and understanding. MedCana is proud to be part of an industry that advocates for sensible cannabis regulation and equitable access to this vital medicine.”

To view the full press release, visit https://cnw.fm/vZMmv

About Software Effective Solutions

Software Effective Solutions/MedCana is a holding company focused on developing companies in the agricultural technology and the cannabis industries. As MedCana moves forward with its expansion plans, the company remains committed to delivering on its promise of building a solid foundation for future growth of its holdings. For more information, visit the company’s website at www.MedCana.net.

NOTE TO INVESTORS: The latest news and updates relating to SFWJ are available in the company’s newsroom at https://cnw.fm/SFWJ

About CBDWire

CBDWire (“CBDW”) is a specialized communications platform with a focus on CBD related news and updates in the cannabidiol (“CBD”) sector. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, CBDW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, CBDW brings its clients unparalleled recognition and brand awareness.

CBDW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from CBDWire, text “CBDWire” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://www.CBDWire.com/Disclaimer

CBDWire
Denver, CO
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com

CBDWire is powered by IBN

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.